Investor Relations



Investors
& Media

At Travere Therapeutics, we are in rare for life

We come together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow.

 

Learn More

Financial Highlights

$76M

U.S. total net product sales

$56M

U.S. net product sales of FILSPARI®

703

new patient start forms for FILSPARI®

$322M

cash, cash equivalents, and marketable securities

Latest Presentation

Upcoming & Recent Events

Investor Factsheet